Collins Cynthia
SEC insider (Form 3/4/5 filer). CIK 0001405692. Director at MAXCYTE, INC. (MXCT) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in REDWOOD CITY, CA.
Companies Collins Cynthia has filed insider reports for
- MAXCYTE, INC. (MXCT): Director
- CODEXIS, INC. (CDXS): Director
- Certara, Inc. (CERT): Director
- Poseida Therapeutics, Inc. (PSTX): Director
Collins Cynthia
CIK: 0001405692
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 17, 2026MXCT
MAXCYTE, INC.
AwardDirect30.4K shares- - Jun 17, 2026CDXS
CODEXIS, INC.
AwardDirectStock Option (Right to Buy)
66.4K shares- - May 14, 2026CERT
Certara, Inc.
ExerciseDirect15.8K shares- - Jun 18, 2025MXCT
MAXCYTE, INC.
AwardDirect29.2K shares- - Jun 10, 2025CDXS
CODEXIS, INC.
AwardDirect41K shares- - May 21, 2025CERT
Certara, Inc.
ExerciseDirect11.9K shares- - May 21, 2025CERT
Certara, Inc.
AwardDirectRestricted Stock Units
15.8K shares- - Mar 28, 2025CDXS
CODEXIS, INC.
AwardDirect71.2K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect59K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
87.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 | MXCT MAXCYTE, INC. | Award | 30,421 | - | $0 | Direct |
| Jun 17, 2026 | CDXS CODEXIS, INC. | Award Stock Option (Right to Buy) | 66,350 | - | - | Direct |
| May 14, 2026 | CERT Certara, Inc. | Exercise | 15,757 | - | $0 | Direct |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | Award | 29,210 | - | - | Direct |
| Jun 10, 2025 | CDXS CODEXIS, INC. | Award | 40,983 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Exercise | 11,928 | - | - | Direct |
| May 21, 2025 | CERT Certara, Inc. | Award Restricted Stock Units | 15,757 | - | - | Direct |
| Mar 28, 2025 | CDXS CODEXIS, INC. | Award | 71,174 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Tender Offer | 58,950 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 87,440 | - | - | Direct |
1-10 of 14 transactions